| Recruiting | Electroencephalogram Predicts Post-operative Delirium Neurosurgery, Delirium - Postoperative, Brain Tumor Adult | — | 2025-03-01 |
| Recruiting | Mechanical Ventilation on Hippocampus Mechanical Ventilation Complication, Brain Injuries | — | 2024-05-08 |
| Completed | M-I/E for Preventing VAP in Post-neurosurgical Patients Ventilator Associated Pneumonia, Brain Injuries, Mechanical Insufflation-exsufflation | — | 2024-03-04 |
| Completed | Intraoperative Diaphragmatic Neuromodulation Neurosurgery, Phrenic Nerve Stimulation, Postoperative Delirium | N/A | 2024-02-26 |
| Recruiting | Post-neurosurgical Respiratory Muscle Dysfunction Diaphragm Issues, Neurosurgery, Pulmonary Complication | — | 2023-07-01 |
| Active Not Recruiting | Retrospective Study of Germ Cell Tumors of the Central Nervous System Germ Cell Tumor of CNS | — | 2023-06-01 |
| Recruiting | Modified CV Regimen in Optic Pathway Glioma Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma | Phase 2 | 2022-04-13 |
| Terminated | Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM) Recurrent Glioblastoma | Phase 2 | 2021-06-27 |
| Completed | Glioblastoma Response Prediction to Apatinib Glioblastoma | — | 2021-04-22 |
| Completed | Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas Low-grade Glioma, Pediatric Brain Tumor | Phase 2 | 2020-11-03 |
| Recruiting | Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Ch Recurrent Medulloblastoma | Phase 2 | 2020-10-28 |
| Recruiting | Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults Recurrent Atypical/malignant Meningioma | N/A | 2020-08-18 |
| Recruiting | Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas Glioblastoma, Recurrent, Lower Grade Glioma, Recurrent | Phase 2 | 2020-02-13 |
| Recruiting | Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL) Primary Central Nervous System Lymphoma | Phase 2 | 2020-02-13 |
| Unknown | Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme Glioblastoma Multiforme | Phase 1 | 2016-07-01 |
| Unknown | Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme Glioblastoma Multiforme | Phase 1 | 2016-07-01 |
| Completed | A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma | Phase 2 | 2015-01-01 |